查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1869603

专业化PACS（个人影像通讯系统）市场规模、份额和趋势分析报告：按专业化、部署模式、最终用途、地区和细分市场预测（2025-2033年）

Specialty Picture Archiving And Communication System Market Size, Share & Trends Analysis Report By Specialty, By Deployment Mode, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 190 Pages | 商品交期: 2-10个工作天内

价格

专业PACS（影像存檔和通讯系统）市场摘要

2024年全球专业PACS（影像存檔和通讯系统）市场规模估计为37.4亿美元，预计2033年将达到65.7亿美元。

预计从 2025 年到 2033 年，该行业将以 6.6% 的复合年增长率成长。这一增长归功于数位成像解决方案的日益普及、医学影像检查数量的增加、对远端放射学和远距离诊断的需求不断增长、政府对医疗保健 IT 普及的倡议和监管支持，以及云端基础的PACS 解决方案的技术进步。

此外，人工智慧 (AI) 与专业影像归檔和通讯系统 (PACS) 的日益融合是塑造市场的另一个新兴趋势。医学影像检查数量的不断增长是专业 PACS 产业发展的关键驱动因素。这一增长是由慢性病患病率上升、人口老化以及诊断成像技术的进步所推动的，这些进步拓展了诊断能力。随着心臟病学、乳房X光检查、整形外科和牙科等专科的扫描量不断增加，医疗机构在储存、搜寻和管理大量复杂影像资料方面面临日益严峻的挑战。根据《美国放射学会杂誌》报导，诊断成像的使用率预计将从2023年的16.9%增长到2055年的26.9%，凸显了对高效影像管理系统日益增长的需求。这进一步强调了对专业 PACS（影像存檔和通讯系统）解决方案的必要性，这些解决方案提供客製化的工作流程、高级视觉化功能和高效的资料管理，以便更快地进行解读、增强协作并改善患者预后。

远距放射学的日益普及正在推动专业PACS（影像归檔和通讯系统）市场的成长。医疗机构越来越依赖远距离诊断服务来应对放射科医生短缺的问题，扩大专业技术的取得管道，并实现观察报告。 Merative预测，2033年，美国可能面临高达42,000名放射科医师的缺口。远距放射学能够即时实现多地点共用医学影像，包括CT、MRI、乳房X光摄影超音波，从而加快诊断速度并确保医疗服务的连续性，尤其是在农村和医疗资源匮乏的地区。专业PACS（影像归檔和通讯系统）解决方案透过提供基于云端基础的存取、安全的影像共用和特定专业的流程来满足这一需求，从而实现放射科医生和转诊医生之间跨地域的无缝协作。这有助于提高效率、缩短报告时间并提升诊断准确性。

目录

第一章调查方法和范围

第二章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 产业机会分析
    • 产业问题分析
    • 技术概述
    • 企业级安全与合规性概述
    • 案例研究
  • 商业环境分析
    • 波特五力分析
    • PESTLE分析

第四章 专业PACS（影像归檔与通讯系统）市场：专业评估与趋势分析

  • 专业细分仪表板
  • 专业市占率变化分析，2024 年及 2033 年
  • 按专业领域分類的市场规模、预测与趋势分析，2021-2033年
  • 放射科 PACS
  • 心臟病学PACS
  • 乳房X光摄影PACS
  • 整形外科PACS
  • 眼科PACS
  • 病理PACS
  • 肿瘤/放射治疗PACS
  • 其他的

第五章 专业PACS市场：部署模式估算及趋势分析

  • 已部署模式仪表板
  • 按部署模式分類的市场份额变化分析（2024 年和 2033 年）
  • 按部署模式分類的市场规模、预测与趋势分析，2021-2033年
  • 云端基础/基于网络
  • 本地部署
  • 杂交种

6. 专业PACS市场：终端用户估算与趋势分析

  • 最终用户细分仪表板
  • 2024 年及 2033 年最终用户市占率变化分析
  • 按最终用途分類的市场规模、预测和趋势分析，2021-2033年
  • 医院
  • 专科诊所
  • 诊断影像中心
  • 远端医疗和远距放射学服务提供者
  • 其他的

第七章 专业PACS（个人影像控制系统）市场：区域估算与趋势分析

  • 区域市场概览
  • 区域市场：主要结论
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 参与者概览
  • 企业市场分析/企业市占率分析（2024 年）
  • 公司分类
  • 策略规划
  • 公司简介
    • Novarad
    • INFINITT North America Inc.
    • Sectra AB
    • Intelerad
    • Koninklijke Philips NV
    • GE HealthCare
    • FUJIFILM Corporation
    • Canon Medical Systems, USA.
    • Agfa HealthCare
    • Merative
    • Ramsoft
    • Optum, Inc.
    • Siemens Healthineers AG
    • Medstrat
    • Candelis Corporation
    • Phoenix Ortho
Product Code: GVR-4-68040-762-9

Specialty PACS Market Summary

The global specialty picture archiving and communication system market size was estimated at USD 3.74 billion in 2024 and is projected to reach USD 6.57 billion by 2033, growing at a CAGR of 6.6% from 2025 to 2033. This growth is attributed to rising adoption of digital imaging solutions, the increasing volume of medical imaging procedures, growing demand for tele radiology and remote diagnostics, Government initiatives and regulatory support for healthcare IT adoption, and Technological advancements in cloud-based PACS solutions.

Moreover, the growing integration of artificial intelligence (AI) into specialty PACS is an emerging trend shaping the market. The increasing volume of medical imaging procedures is a major driver for the specialty (Picture Archiving And Communication System) PACS industry. The growth is fueled by the rising prevalence of chronic diseases, an aging population, and advances in imaging modalities that expand diagnostic capabilities. As more scans are performed across specialties such as cardiology, mammography, orthopedics, and dentistry, healthcare providers face growing challenges in storing, retrieving, and managing large volumes of complex image data. According to the Journal of the American College of Radiology, imaging utilization is projected to rise from 16.9% in 2023 to 26.9% by 2055, highlighting the accelerating demand for efficient imaging management systems which further emphasizes the need for specialty PACS solutions that offer tailored workflows, advanced visualization, and streamlined data management to enable faster interpretation, improved collaboration, and better patient outcomes.

Rising adoption of tele radiology is driving growth in the specialty PACS market, as healthcare providers increasingly rely on remote diagnostic services to address radiologist shortages, expand access to expertise, and enable around-the-clock reporting. According to Merative, by 2033, the U.S. could face a shortage of up to 42,000 radiologists. Tele radiology allows medical images from modalities such as CT, MRI, mammography, and ultrasound to be shared instantly across locations, supporting faster diagnoses and continuity of care, particularly in rural or underserved regions. Specialty PACS solutions complement this demand by offering cloud-based access, secure image sharing, and specialty-specific workflows that ensure seamless collaboration between radiologists and referring physicians across geographies, improving efficiency, turnaround times, and diagnostic accuracy.

Global Specialty PACS Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global specialty PACS market report based on specialty, deployment mode, end use, and region:

  • Specialty Outlook (Revenue, USD Million, 2021 - 2033)
  • Radiology PACS
  • Cardiology PACS
  • Mammography PACS
  • Orthopedic PACS
  • Ophthalmology PACS
  • Pathology PACS
  • Oncology / Radiation Therapy PACS
  • Others
  • Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • Cloud-Based/ Web-Based
  • On-premise
  • Hybrid
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Diagnostic Imaging Centers
  • Telemedicine & Tele radiology Providers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Specialty
    • 1.2.2. Deployment Mode
    • 1.2.3. End use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising adoption of digital imaging solutions
      • 3.2.1.2. Increasing volume of medical imaging procedures
      • 3.2.1.3. Expanding remote access and telemedicine adoption
      • 3.2.1.4. Growing demand for specialty-specific imaging
      • 3.2.1.5. Increasing integration with EHR/EMR and RIS systems
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High implementation and maintenance costs
      • 3.2.2.2. Data privacy and security concerns
      • 3.2.2.3. Limited availability of skilled workforce to operate and manage PACS
      • 3.2.2.4. Complex and varying regulatory requirements across regions
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
    • 3.2.5. Technology Overview
      • 3.2.5.1. AI & Machine Learning
      • 3.2.5.2. 3D Visualization & Reconstruction
      • 3.2.5.3. Automated Workflow & Reporting Tools
      • 3.2.5.4. Cloud Storage & Remote Access
    • 3.2.6. Company-Level Security & Compliance Overview
    • 3.2.7. Case Studies
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. Specialty PACS Market: Specialty Estimates & Trend Analysis

  • 4.1. Specialty Segment Dashboard
  • 4.2. Specialty Market Share Movement Analysis, 2024 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by Specialty, 2021 to 2033 (USD Million)
  • 4.4. Radiology PACS
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Cardiology PACS
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Mammography PACS
    • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Orthopedic PACS
    • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Ophthalmology PACS
    • 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Pathology PACS
    • 4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10. Oncology / Radiation Therapy PACS
    • 4.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11. Others
    • 4.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Specialty PACS Market: Deployment Mode Estimates & Trend Analysis

  • 5.1. Deployment Mode Dashboard
  • 5.2. Deployment Mode Market Share Movement Analysis, 2024 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by Deployment Mode, 2021 to 2033 (USD Million)
  • 5.4. Cloud-Based/ Web-Based
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. On-Premise
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Hybrid
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Specialty PACS Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. End Use Market Share Movement Analysis, 2024 & 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Specialty Clinics
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Diagnostic Imaging Centers
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Telemedicine & Tele radiology Providers
    • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Specialty PACS Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market: Key Takeaways
  • 7.3. North America
    • 7.3.1. North America Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Competitive insights
      • 7.3.2.4. U.S. Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Competitive insights
      • 7.3.3.4. Canada Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Regulatory framework
      • 7.3.4.3. Competitive insights
      • 7.3.4.4. Mexico Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive insights
      • 7.4.2.4. Germany Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. UK
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive insights
      • 7.4.3.4. UK Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive insights
      • 7.4.4.4. France Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Competitive insights
      • 7.4.5.4. Italy Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Competitive insights
      • 7.4.6.4. Spain Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Competitive insights
      • 7.4.7.4. Denmark Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework
      • 7.4.8.3. Competitive insights
      • 7.4.8.4. Sweden Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework
      • 7.4.9.3. Competitive insights
      • 7.4.9.4. Norway Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive insights
      • 7.5.2.4. Japan Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive insights
      • 7.5.3.4. China Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive insights
      • 7.5.4.4. India Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive insights
      • 7.5.5.4. South Korea Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive insights
      • 7.5.6.4. Australia Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive insights
      • 7.5.7.4. Thailand Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Specialty PACS Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive insights
      • 7.6.2.4. Brazil Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive insights
      • 7.6.3.4. Argentina Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive insights
      • 7.7.2.4. South Africa Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive insights
      • 7.7.3.4. Saudi Arabia Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive insights
      • 7.7.4.4. UAE Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework
      • 7.7.5.3. Competitive insights
      • 7.7.5.4. Kuwait Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis/Company Market Share Analysis (2024)
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Novarad
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Product benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. INFINITT North America Inc.
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Product benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. Sectra AB
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Product benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. Intelerad
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Product benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. Koninklijke Philips N.V.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Product benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. GE HealthCare
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Product benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. FUJIFILM Corporation
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Canon Medical Systems, USA.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Agfa HealthCare
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Merative
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Ramsoft
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Product benchmarking
      • 8.5.11.4. Strategic initiatives
    • 8.5.12. Optum, Inc.
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial performance
      • 8.5.12.3. Product benchmarking
      • 8.5.12.4. Strategic initiatives
    • 8.5.13. Siemens Healthineers AG
      • 8.5.13.1. Overview
      • 8.5.13.2. Financial performance
      • 8.5.13.3. Product benchmarking
      • 8.5.13.4. Strategic initiatives
    • 8.5.14. Medstrat
      • 8.5.14.1. Overview
      • 8.5.14.2. Financial performance
      • 8.5.14.3. Product benchmarking
      • 8.5.14.4. Strategic initiatives
    • 8.5.15. Candelis Corporation
      • 8.5.15.1. Overview
      • 8.5.15.2. Financial performance
      • 8.5.15.3. Product benchmarking
      • 8.5.15.4. Strategic initiatives
    • 8.5.16. Phoenix Ortho
      • 8.5.16.1. Overview
      • 8.5.16.2. Financial performance
      • 8.5.16.3. Product benchmarking
      • 8.5.16.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 List of secondary data sources
  • Table 3 North America Specialty PACS market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 5 North America Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 6 North America Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 7 US Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 8 US Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 9 US Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 10 Canada Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 11 Canada Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 12 Canada Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Mexico Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 14 Mexico Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 15 Mexico Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Europe Specialty PACS market, by country, 2021 - 2033 (USD Million)
  • Table 17 Europe Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 18 Europe Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 19 Europe Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Germany Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 21 Germany Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 22 Germany Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 23 UK Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 24 UK Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 25 UK Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 26 France Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 27 France Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 28 France Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 29 Italy Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 30 Italy Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 31 Italy Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Spain Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 33 Spain Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 34 Spain Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Sweden Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 36 Sweden Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 37 Sweden Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Denmark Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 39 Denmark Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 40 Denmark Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Norway Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 42 Norway Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 43 Norway Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific Specialty PACS market, by country, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 48 China Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 49 China Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 50 China Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 51 Japan Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 52 Japan Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 53 Japan Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 54 India Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 55 India Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 56 India Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Australia Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 58 Australia Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 59 Australia Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 60 Thailand Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 61 Thailand Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 62 Thailand Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 63 South Korea Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 64 South Korea Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 65 South Korea Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Latin America Specialty PACS market, by country, 2021 - 2033 (USD Million)
  • Table 67 Latin America Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 68 Latin America Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 69 Latin America Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Brazil Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 71 Brazil Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 72 Brazil Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 73 Argentina Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 74 Argentina Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 75 Argentina Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 76 MEA Specialty PACS market, by country, 2021 - 2033 (USD Million)
  • Table 77 MEA Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 78 MEA Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 79 MEA Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 80 South Africa Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 81 South Africa Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 82 South Africa Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 86 UAE Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 87 UAE Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 88 UAE Specialty PACS market, by end use, 2021 - 2033 (USD Million)
  • Table 89 Kuwait Specialty PACS market, by Specialty, 2021 - 2033 (USD Million)
  • Table 90 Kuwait Specialty PACS market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 91 Kuwait Specialty PACS market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Specialty PACS market: Market outlook
  • Fig. 5 Specialty PACS market: Segment outlook
  • Fig. 6 Specialty PACS market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Specialty PACS market Driver Impact
  • Fig. 9 Specialty PACS market Restraint impact
  • Fig. 10 Specialty PACS market, specialty outlook: Key takeaways, (USD Million)
  • Fig. 11 Specialty PACS market: specialty movement analysis (USD Million)
  • Fig. 12 Radiology PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Cardiology PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Mammography PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Orthopedic PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Ophthalmology PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Pathology PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Oncology / Radiation Therapy PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Specialty PACS market, deployment mode outlook key takeaways (USD Million)
  • Fig. 21 Specialty PACS market: deployment mode movement analysis (USD Million)
  • Fig. 22 Cloud-Based/Web-Based market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 On-Premise market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Hybrid market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Specialty PACS market, end use outlook key takeaways (USD Million)
  • Fig. 26 Specialty PACS market: end use movement analysis (USD Million)
  • Fig. 27 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Specialty Clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Diagnostic Imaging Centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Telemedicine & Teleradiology Providers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 Specialty PACS market: Regional outlook, 2024 & 2033
  • Fig. 34 North America Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 US Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Canada Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Mexico Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Europe Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 UK Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Germany Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 France Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Italy Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Spain Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Denmark Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Sweden Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Norway Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Asia Pacific Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Japan Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 China Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 India Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 South Korea Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Australia Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Thailand Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Latin America Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Brazil Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 MEA Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 South Africa Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Saudi Arabia Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 UAE Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Kuwait Specialty PACS market estimates and forecasts, 2021 - 2033 (USD Million)